Enhancement of Fas-mediated apoptosis in ageing human keratinocytes.

Mech Ageing Dev

The Myers Skin Biochemistry Laboratory, Department of Biological Chemistry, The Hebrew University, Givat Ram, Jerusalem 91904, Israel.

Published: March 2004

Cellular senescence and apoptosis are two metabolically related and seemingly synergistic processes that are involved in tissue maintenance and homeostasis, anti-tumor protection, and age-related diseases. Despite this apparent co-operativity, senescence can inhibit apoptosis in certain conditions. Here, we describe senescence-apoptosis relationships in human epidermal cells by comparing apoptosis-related effector concentrations in keratinocyte cultures and epidermal skin cells at various stages of ageing. Using western blots, flow cytometry, enzyme-linked immuno-sorbent assay (ELISA) and immunofluorescence, we determined the amounts of apoptotic effectors in aged cells compared to young ones, in parallel with beta-galactosidase activity at neutral pH (senescence-associated beta-galactosidase, SA beta-gal), found to be a good indicator of cellular ageing. We observed increased levels of several Fas-mediated apoptosis effectors (Fas, Fas ligand, FADD, FLICE), both in cell cultures at advanced passages and in skin cells of aged donors (above 45 years). Furthermore, we found that while the pro-apoptotic p53 increased, the anti-apoptotic Bcl-2 declined. In spite of this, the extent of spontaneous apoptosis did not change in senescent keratinocyte cultures. The cells, however, became notably more susceptible to apoptosis when kept in exhausted growth medium, or upon Fas receptor activation by anti-Fas antibody binding. Our results are consistent with recent findings in senescent fibroblasts, showing that the death-signaling pathway is enhanced at senescence.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mad.2003.12.007DOI Listing

Publication Analysis

Top Keywords

fas-mediated apoptosis
8
keratinocyte cultures
8
skin cells
8
apoptosis
6
cells
5
enhancement fas-mediated
4
apoptosis ageing
4
ageing human
4
human keratinocytes
4
keratinocytes cellular
4

Similar Publications

An engineered Palivizumab IgG2 subclass for synthetic gp130 and fas mediated signaling.

J Biol Chem

January 2025

Institute of Biochemistry and Molecular Biology II, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University, Düsseldorf, Germany. Electronic address:

Recently, we phenocopied Interleukin (IL-)6 signaling using the dimerized single-chain variable fragment (scFv) derived from the respiratory syncytial virus (RSV) IgG1-antibody Palivizumab (PLHFc) to activate a Palivizumab anti-idiotypic nanobody (AIP)-gp130 receptor fusion protein. Palivizumab was unable to activate STAT3 signaling, so we aimed to create a similar ligand capable of triggering this pathway. Here, we created three variants of the ligand called PLH0Fc, PLH4Fc and PLH8Fc by shortening the spacer region connecting PLH and Fc from 23 amino acids in PLHFc to 0 amino acids or expanding it by rigid linkers of 4 or 8 alpha helical loops, respectively.

View Article and Find Full Text PDF

The TNF-TNFR1 signaling pathway plays a pivotal role in regulating the balance between cell survival and cell death. Upon binding to TNF, plasma membrane-localized TNFR1 initiates survival signaling, whereas TNFR1 internalization promotes caspase-mediated apoptosis. We previously reported that the α2-6 sialylation of TNFR1 by the tumor-associated sialyltransferase ST6GAL1 diverts signaling toward survival by inhibiting TNFR1 internalization.

View Article and Find Full Text PDF
Article Synopsis
  • MRL/lpr mice, which typically develop autoimmune symptoms similar to systemic lupus erythematosus due to FAS-mediated apoptosis issues, were studied to understand the role of EAF2 in this process.
  • Researchers created EAF2-deficient mice and found that this deficiency led to reduced symptoms like lymphadenopathy, splenomegaly, and nephritis while also extending the mice's lifespan.
  • The study concluded that the lack of EAF2 causes B cells to become hyperactivated but ultimately die off faster due to changes in gene expression, helping reduce autoimmune responses in these mice.
View Article and Find Full Text PDF

Inhibition of MAT2A Impairs Skeletal Muscle Repair Function.

Biomolecules

September 2024

Metabolic Control and Aging-Jiangxi Key Laboratory of Aging and Diseases, Human Aging Research Institute (HARI), School of Life Science, Nanchang University, Nanchang 330031, China.

The regenerative capacity of muscle, which primarily relies on anabolic processes, diminishes with age, thereby reducing the effectiveness of therapeutic interventions aimed at treating age-related muscle atrophy. In this study, we observed a decline in the expression of methionine adenosine transferase 2A (MAT2A), which synthesizes S-adenosylmethionine (SAM), in the muscle tissues of both aged humans and mice. Considering MAT2A's critical role in anabolism, we hypothesized that its reduced expression contributes to the impaired regenerative capacity of aging skeletal muscle.

View Article and Find Full Text PDF

HSPB4/CRYAA Protect Photoreceptors during Retinal Detachment in Part through FAIM2 Regulation.

Neurol Int

August 2024

Department of Ophthalmology and Visual Sciences, W.K. Kellogg Eye Center, University of Michigan, Ann Arbor, MI 48105, USA.

Article Synopsis
  • This study looked at how a protein called α-crystallin helps protect special cells in the eye (called photoreceptors) when the retina gets separated from its layers.
  • Researchers tested this using rat and mouse eyes and found out that α-crystallin levels increase quickly when the retina gets detached.
  • They discovered that αA-crystallin not only helps keep photoreceptors alive but also works with another protein called FAIM2 to do this job better, especially when αA-crystallin is changed in a certain way (phosphorylation).
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!